학술논문

Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial
Document Type
Article
Source
In: The Lancet. (The Lancet, 24 June 2023, 401(10394):2138-2147)
Subject
Language
English
ISSN
1474547X
01406736